Companies/US/IRD

OPUS GENETICS, INC.

Last · NasdaqCM$4.64-0.01 (-0.22%)stale · yahoo · 63h ago
Vol 1.62M ≈ 7.52M
Market cap$386.03M83.2M sh
P/E · TTM-3.7fwd -6.5 · eps -1.27 · loss
Beta0.62vs S&P 500
Div yield0.00%annual · TTM
52w range
$1.70$7.07
Volume1.6Msession

Issuer

Legal nameOPUS GENETICS, INC.
HQUnited States (US)
ListingUS IRD
ISINUS67577R1023
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001228627
CIK0001228627
Employees28
AddressOcuphire Pharma, Inc. 8 Davis Drive 27709, Durham
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.15
Est. revenue
2.1M

Earnings transcripts

1 recent

Press & signals

2 recent
  • GlobeNewswire

    Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • GlobeNewswire

    Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Documents

FormReporting forFiledFlags
2026-09-302026-10-020
2026-09-092026-09-110
2026-09-082026-09-080